Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Suzanne Oparil

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Procedures

Double-Blind Method

Concepts & Ideas

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
91
Chen, Yiu-Fai
49
Wyss, Michael
40
Kjeldsen, Sverre
32
Meng, Qing
23
Nieminen, Markku
23
Dahlöf, Björn
22
de Faire, Ulf
22
Lindholm, Lars
22
Lederballe-Pedersen, Ole
22
Ibsen, Hans
22
Fyhrquist, Frej
22
Omvik, Per
20
Julius, Stevo
18
Devereux, Richard
18
Wedel, Hans

Sign-in to see all Coauthors

Publications

TOP 3
Neutel Joel M; Franklin Stanley S; Bhaumik Amitabha; Lapuerta Pablo; Oparil Suzanne
Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension.
Chrysant Steven G; Oparil Suzanne; Melino Michael; Karki Sulekha; Lee James; Heyrman Reinilde
Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
Pimenta Eduardo; Gaddam Krishna K; Oparil Suzanne; Aban Inmaculada; Husain Saima; Dell'Italia Louis J; Calhoun David A
Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Suzanne Oparil (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Neutel Joel M; Franklin Stanley S; Bhaumik Amitabha; Lapuerta Pablo; Oparil Suzanne
Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2009;31(7):572-84.
2009: Chrysant Steven G; Oparil Suzanne; Melino Michael; Karki Sulekha; Lee James; Heyrman Reinilde
Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(9):475-82.
2009: Pimenta Eduardo; Gaddam Krishna K; Oparil Suzanne; Aban Inmaculada; Husain Saima; Dell'Italia Louis J; Calhoun David A
Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.
Hypertension 2009;54(3):475-81.
2009: Acelajado Maria Czarina; Oparil Suzanne
Hypertension in the elderly.
Clinics in geriatric medicine 2009;25(3):391-412.
2009: Appel Lawrence J; Giles Thomas D; Black Henry R; Izzo Joseph L; Materson Barry J; Oparil Suzanne; Weber Michael A
ASH Position Paper: Dietary approaches to lower blood pressure.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(7):358-68.
2009: Pimenta Eduardo; Oparil Suzanne
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.
Therapeutics and clinical risk management 2009;5(3):459-64.
2009: Wright Jackson T; Probstfield Jeffrey L; Cushman William C; Pressel Sara L; Cutler Jeffrey A; Davis Barry R; Einhorn Paula T; Rahman Mahboob; Whelton Paul K; Ford Charles E; Haywood L Julian; Margolis Karen L; Oparil Suzanne; Black Henry R; Alderman Michael H;
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
Archives of internal medicine 2009;169(9):832-42.
2009: Oparil Suzanne
Hormone therapy of premature ovarian failure: the case for "natural" estrogen.
Hypertension 2009;53(5):745-6.
2009: Nicola Teodora; Hagood James S; James Masheika L; Macewen Mark W; Williams Timothy A; Hewitt Matthew M; Schwiebert Lisa; Bulger Arlene; Oparil Suzanne; Chen Yiu-Fai; Ambalavanan Namasivayam
Loss of Thy-1 inhibits alveolar development in the newborn mouse lung.
American journal of physiology. Lung cellular and molecular physiology 2009;296(5):L738-50.
2009: Zanchetti Alberto; Mancia Giuseppe; Black Henry R; Oparil Suzanne; Waeber Bernard; Schmieder Roland E; Bakris George L; Messerli Franz H; Kjeldsen Sverre E; Ruilope Luis M
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
Journal of hypertension 2009;27(4):673-9.
2009: Oparil Suzanne; Weber Michael
Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
Postgraduate medicine 2009;121(2):25-39.
2009: Olsen Michael Hecht; Wachtell Kristian; Beevers Gareth; Dahlöf Björn; de Simone Giovanni; Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Lindholm Lars H; Lyle Paulette A; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2009;27(3):567-74.
2009: Pimenta Eduardo; Calhoun David A; Oparil Suzanne
Sleep apnea, aldosterone, and resistant hypertension.
Progress in cardiovascular diseases 2009;51(5):371-80.
2009: Xing Dongqi; Nozell Susan; Chen Yiu-Fai; Hage Fadi; Oparil Suzanne
Estrogen and mechanisms of vascular protection.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(3):289-95.
2009: Laczy Boglarka; Hill Bradford G; Wang Kai; Paterson Andrew J; White C Roger; Xing Dongqi; Chen Yiu-Fai; Darley-Usmar Victor; Oparil Suzanne; Chatham John C
Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.
American journal of physiology. Heart and circulatory physiology 2009;296(1):H13-28.
2009: Pimenta Eduardo; Oparil Suzanne
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.
Vascular health and risk management 2009;5(1):453-63.
2009: Oparil Suzanne; Kjeldsen Sverre E; Hedner Thomas; Narkiewicz Krzysztof
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Blood pressure 2009;18(1-2):4-6.
2008: Oparil Suzanne; Chrysant Steven G; Kereiakes Dean; Xu Jianbo; Chavanu Kathleen J; Waverczak William; Dubiel Robert
Results of an olmesartan medoxomil-based treatment regimen in hypertensive patients.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(12):911-21.
2008: Pimenta Eduardo; Oparil Suzanne
Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Cardiology clinics 2008;26(4):527-35.
2008: Guimbellot Jennifer S; Fortenberry James A; Siegal Gene P; Moore Bryan; Wen Hui; Venglarik Charles; Chen Yiu-Fai; Oparil Suzanne; Sorscher Eric J; Hong Jeong S
Role of oxygen availability in CFTR expression and function.
American journal of respiratory cell and molecular biology 2008;39(5):514-21.
2008: Pimenta Eduardo; Oparil Suzanne
Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: American perspective.
Polskie archiwum medycyny wewn?trznej 2008;118(9):508-12.
2008: Gaddam Krishna K; Oparil Suzanne
Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
Current opinion in nephrology and hypertension 2008;17(5):484-90.
2008: Biederman Robert W W; Doyle Mark; Young Alistair A; Devereux Richard B; Kortright Eduardo; Perry Gilbert; Bella Jonathan N; Oparil Suzanne; Calhoun David; Pohost Gerald M; Dell'Italia Louis J
Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
Hypertension 2008;52(2):279-86.
2008: Carter Barry L; Einhorn Paula T; Brands Michael; He Jiang; Cutler Jeffrey A; Whelton Paul K; Bakris George L; Brancati Frederick L; Cushman William C; Oparil Suzanne; Wright Jackson T;
Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute.
Hypertension 2008;52(1):30-6.
2008: Ambalavanan Namasivayam; Nicola Teodora; Hagood James; Bulger Arlene; Serra Rosa; Murphy-Ullrich Joanne; Oparil Suzanne; Chen Yiu-Fai
Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung.
American journal of physiology. Lung cellular and molecular physiology 2008;295(1):L86-95.
2008: Xing Dongqi; Feng Wenguang; Nöt Laszlo G; Miller Andrew P; Zhang Yun; Chen Yiu-Fai; Majid-Hassan Erum; Chatham John C; Oparil Suzanne
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.
American journal of physiology. Heart and circulatory physiology 2008;295(1):H335-42.
2008: Pimenta Eduardo; Oparil Suzanne
Beyond brachial pressure effect.
Current hypertension reports 2008;10(3):213-5.
2008: Hedner Thomas; Oparil Suzanne; Narkiewicz Krzysztof; Kjeldsen Sverre E
Achieving better blood pressure control.
Blood pressure. Supplement 2008;1():3-4.
2008: Gaddam Krishna K; Nishizaka Mari K; Pratt-Ubunama Monique N; Pimenta Eduardo; Aban Inmaculada; Oparil Suzanne; Calhoun David A
Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.
Archives of internal medicine 2008;168(11):1159-64.
2008: Oparil S; Abate N; Chen E; Creager M A; Galet V; Jia G; Julius S; Lerman A; Lyle P A; Pool J; Tershakovec A M
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
Current medical research and opinion 2008;24(4):1101-14.
2008: Os Ingrid; Franco Veronica; Kjeldsen Sverre E; Manhem Karin; Devereux Richard B; Gerdts Eva; Hille Darcy A; Lyle Paulette A; Okin Peter M; Dahlöf Björn; Oparil Suzanne
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Hypertension 2008;51(4):1103-8.
2008: Pimenta Eduardo; Gaddam Krishna K; Oparil Suzanne
Mechanisms and treatment of resistant hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(3):239-44.
2008: Pimenta Eduardo; Gaddam Krishna K; Pratt-Ubunama Monique N; Nishizaka Mari K; Aban Inmaculada; Oparil Suzanne; Calhoun David A
Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.
Hypertension 2008;51(2):339-44.
2008: Li Peng; Wang Dajun; Lucas Jason; Oparil Suzanne; Xing Dongqi; Cao Xu; Novak Lea; Renfrow Matthew B; Chen Yiu-Fai
Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
Circulation research 2008;102(2):185-92.
2008: Xing Dongqi; Hage Fadi G; Chen Yiu-Fai; McCrory Mark A; Feng Wenguang; Skibinski Gregory A; Majid-Hassan Erum; Oparil Suzanne; Szalai Alexander J
Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent.
The American journal of pathology 2008;172(1):22-30.
2008: Ambalavanan Namasivayam; Nicola Teodora; Li Peng; Bulger Arlene; Murphy-Ullrich Joanne; Oparil Suzanne; Chen Yiu-Fai
Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions.
Pediatric research 2008;63(1):26-32.
2008: Pimenta Eduardo; Oparil Suzanne
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.
Vascular health and risk management 2008;4(3):653-64.
2008: Kjeldsen Sverre E; Hedner Thomas; Narkiewicz Krzystof; Oparil Suzanne
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
Blood pressure 2008;17(3):132-3.
2008: Hedner Thomas; Oparil Suzanne; Narkiewicz Krzysztof; Kjeldsen Sverre E
Achieving better blood pressure control.
Blood pressure 2008;17 Suppl 1():3-4.
2008: Kjeldsen Sverre E; Oparil Suzanne; Narkiewicz Krzysztof; Hedner Thomas
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Blood pressure 2008;17(2):68-9.
2008: Hedner Thomas; Kjeldsen Sverre E; Narkiewicz Krzysztof; Oparil Suzanne
Urgent need to address quality control issues of out-of-office blood pressure measurement and patient risk assessment.
Blood pressure 2008;17(1):5-6.
2007: Pimenta Eduardo; Gaddam Krishna K; Pratt-Ubunama Monique N; Nishizaka Mari K; Cofield Stacey S; Oparil Suzanne; Calhoun David A
Aldosterone excess and resistance to 24-h blood pressure control.
Journal of hypertension 2007;25(10):2131-7.
2007: Oparil Suzanne; Yarows Steven A; Patel Samir; Zhang Jack; Satlin Andrew
Dual inhibition of the renin system by aliskiren and valsartan.
Lancet 2007;370(9593):1126-7.
2007: Oparil Suzanne
Renin inhibitors in the management of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(9):706-7.
2007: Oparil Suzanne; Yarows Steven A; Patel Samir; Fang Hui; Zhang Jack; Satlin Andrew
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.
Lancet 2007;370(9583):221-9.
2007: Pimenta Eduardo; Calhoun David A; Oparil Suzanne
Mechanisms and treatment of resistant hypertension.
Arquivos brasileiros de cardiologia 2007;88(6):683-92.
2007: Gaddam Krishna K; Oparil Suzanne
Are current guidelines optimal for treatment of blood pressure in patients with coronary artery disease?
Current hypertension reports 2007;9(3):211-3.
2007: Xing Dongqi; Feng Wenguang; Miller Andrew P; Weathington Nathaniel M; Chen Yiu-Fai; Novak Lea; Blalock J Edwin; Oparil Suzanne
Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation.
American journal of physiology. Heart and circulatory physiology 2007;292(6):H2607-12.
2007: Rosendorff Clive; Black Henry R; Cannon Christopher P; Gersh Bernard J; Gore Joel; Izzo Joseph L; Kaplan Norman M; O'Connor Christopher M; O'Gara Patrick T; Oparil Suzanne;
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.
Circulation 2007;115(21):2761-88.
2007: Moser Marvin; Oparil Suzanne; Cushman William; Papademetriou Vasilios
The ALLHAT study revisited: do newer data from this trial and others indicate changes in treatment guidelines?
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(5):372-80.
2007: Ambalavanan Namasivayam; Li Peng; Bulger Arlene; Murphy-Ullrich Joanne; Oparil Suzanne; Chen Yiu-Fai
Endothelin-1 mediates hypoxia-induced increases in vascular collagen in the newborn mouse lung.
Pediatric research 2007;61(5 Pt 1):559-64.
2007: Oparil Suzanne
Does improving hypertension control involve more than just pills?
Nature clinical practice. Cardiovascular medicine 2007;4(4):182-3.
2007: Giles Thomas D; Oparil Suzanne; Silfani Tonous N; Wang Antonia; Walker J Findlay
Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(3):187-95.
2007: Miller Andrew P; Xing Dongqi; Feng Wenguang; Fintel Marion; Chen Yiu-Fai; Oparil Suzanne
Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries.
Menopause (New York, N.Y.) 2007;14(2):251-60.
2007: Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Harris Katherine E; Ibsen Hans; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Hille Darcy A; Dahlöf Björn
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Current medical research and opinion 2007;23(2):259-70.
2007: Li Peng; Oparil Suzanne; Novak Lea; Cao Xu; Shi Weibin; Lucas Jason; Chen Yiu-Fai
ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells.
Journal of applied physiology (Bethesda, Md. : 1985) 2007;102(1):390-8.
2007: Oparil Suzanne
Hypertension: what it is; what it isn't; how to think about it, to prevent it, and to manage it. Interview by George D. Lundberg.
MedGenMed : Medscape general medicine 2007;9(4):56.
2007: Kjeldsen Sverre E; Oparil Suzanne; Narkiewicz Krzysztof; Hedner Thomas
Ambulatory blood pressure adds to explaining benefits of AT-1 receptor blockade in the treatment of left ventricular hypertrophy.
Blood pressure 2007;16(6):344-6.
2007: Narkiewicz Krzysztof; Kjeldsen Sverre E; Oparil Suzanne; Hedner Thomas
Hypertension and cardiovascular disease: is arterial stiffness the heart of the matter?
Blood pressure 2007;16(4):236-7.
2007: Giles Thomas D; Oparil Suzanne; Pickering Thomas G
Where are we going? Beyond JNC 7.
Preventive cardiology 2007;10(4):222-7.
2007: Hedner T Thomas; Narkiewicz Krzysztof; Kjeldsen Sverre E; Oparil Suzanne;
New ESH/ESC guidelines signal progress in hypertension management.
Blood pressure 2007;16(3):132-4.
2007: Kjeldsen Sverre E; Lyle Paulette A; Kizer Jorge R; Oparil Suzanne; Høieggen Aud; Os Ingrid
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
Vascular health and risk management 2007;3(3):299-305.
2007: Shreenivas Satya; Oparil Suzanne
The role of endothelin-1 in human hypertension.
Clinical hemorheology and microcirculation 2007;37(1-2):157-78.
2007: Kjeldsen Sverre E; Oparil Suzanne; Hedner Thomas; Narkiewicz Krzysztof
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed.
Blood pressure 2007;16(1):4-5.
2006: Neutel Joel M; Franklin Stanley S; Oparil Suzanne; Bhaumik Amitabha; Ptaszynska Agata; Lapuerta Pablo
Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):850-7; quiz 858-9.
2006: Oparil Suzanne
Women and hypertension: what did we learn from the Women's Health Initiative?
Cardiology in review 2006;14(6):267-75.
2006: Franco Veronica; Oparil Suzanne
Is there a new treatment for hypertensive disease in the horizon? Role of soluble guanylate cyclase.
Hypertension 2006;48(5):822-3.
2006: Li Guohong; Oparil Suzanne; Sanders John M; Zhang Lin; Dai Meiru; Chen Lan Bo; Conway Simon J; McNamara Coleen A; Sarembock Ian J
Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.
Atherosclerosis 2006;188(2):292-300.
2006: Piller Linda B; Ford Charles E; Davis Barry R; Nwachuku Chuke; Black Henry R; Oparil Suzanne; Retta Tamrat M; Probstfield Jeffrey L;
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(9):649-56; quiz 657-8.
2006: Franco Veronica; Chen Yiu-Fai; Feng Ji A; Li Peng; Wang Dajun; Hasan Erum; Oparil Suzanne; Perry Gilbert J
Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
Clinical and experimental pharmacology & physiology 2006;33(9):773-9.
2006: Chen Yiu-Fai; Feng Ji-An; Li Peng; Xing Dongqi; Ambalavanan Namasivayam; Oparil Suzanne
Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling.
Life sciences 2006;79(14):1357-65.
2006: Os Ingrid; Gudmundsdottir Helga; Kjeldsen Sverre E; Oparil Suzanne
Treatment of isolated systolic hypertension in diabetes mellitus type 2.
Diabetes, obesity & metabolism 2006;8(4):381-7.
2006: Oparil Suzanne
The ASCOT blood pressure lowering trial.
Current hypertension reports 2006;8(3):229-31.
2006: Franco Veronica; Oparil Suzanne
Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival.
Journal of the American College of Nutrition 2006;25(3 Suppl):247S-255S.
2006: Julius Stevo; Nesbitt Shawna D; Egan Brent M; Weber Michael A; Michelson Eric L; Kaciroti Niko; Black Henry R; Grimm Richard H; Messerli Franz H; Oparil Suzanne; Schork M Anthony;
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
The New England journal of medicine 2006;354(16):1685-97.
2006: Oparil Suzanne; Izzo Joseph L
Pulsology rediscovered: commentary on the Conduit Artery Function Evaluation (CAFE) study.
Circulation 2006;113(9):1162-3.
2006: Chen Yiu-Fai; Feng Ji-An; Li Peng; Xing Dongqi; Zhang Yun; Serra Rosa; Ambalavanan Namasivayam; Majid-Hassan Erum; Oparil Suzanne
Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
Journal of applied physiology (Bethesda, Md. : 1985) 2006;100(2):564-71.
2006: Mishra Rajesh G; Stanczyk Frank Z; Burry Kenneth A; Oparil Suzanne; Katzenellenbogen Benita S; Nealen Michele L; Katzenellenbogen John A; Hermsmeyer R Kent
Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.
American journal of physiology. Heart and circulatory physiology 2006;290(1):H295-303.
2006: Narkiewicz Krzysztof; Kjeldsen Sverre E; Oparil Suzanne; Hedner Thomas
Beta-blockers as sub-optimal treatment for hypertension: time for first-line therapy revision?
Blood pressure 2006;15(6):323-4.
2006: Hedner Thomas; Narkiewicz Krzysztof; Oparil Suzanne; Kjeldsen Sverre E
The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?
Blood pressure 2006;15(5):260-2.
2005: Kjeldsen Sverre E; Lyle Paulette A; Tershakovec Andrew M; Devereux Richard B; Oparil Suzanne; Dahlöf Björn; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Wedel Hans
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Expert opinion on emerging drugs 2005;10(4):729-45.
2005: Wang Dajun; Oparil Suzanne; Chen Yiu-Fai; McCrory Mark A; Skibinski Gregory A; Feng Wenguang; Szalai Alexander J
Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2094-9.
2005: Fossum Eigil; Moan Andreas; Kjeldsen Sverre E; Devereux Richard B; Julius Stevo; Snapinn Steven M; Edelman Jonathan M; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Dahlöf Björn;
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;46(5):770-5.
2005: Moser Marvin; Giles Thomas; Oparil Suzanne
Conflicting and confusing data from the hypertension treatment trials: whom and what should you believe?
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(7):403-8.
2005: Oparil Suzanne; Wright Jackson T
Ethnicity and blood pressure.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(6):357-64.
2005: Oparil Suzanne; Miller Andrew P
Gender and blood pressure.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(5):300-9.
2005: Ambalavanan Namasivayam; Bulger Arlene; Murphy-Ullrich Joanne; Oparil Suzanne; Chen Yiu-Fai
Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling.
Pediatric research 2005;57(5 Pt 1):631-6.
2005: de Simone Giovanni; Wachtell Kristian; Palmieri Vittorio; Hille Darcy A; Beevers Gareth; Dahlöf Björn; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Julius Stevo; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Devereux Richard B
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Circulation 2005;111(15):1924-31.
2005: Fyhrquist Frej; Dahlöf Björn; Devereux Richard B; Kjeldsen Sverre E; Julius Stevo; Beevers Gareth; de Faire Ulf; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Hille Darcy A; Lyle Paulette A; Edelman Jonathan M; Snapinn Steven M; Wedel Hans;
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Hypertension 2005;45(4):580-5.
2005: Kjeldsen Sverre E; Lyle Paulette A; Kizer Jorge R; Dahlöf Björn; Devereux Richard B; Julius Stevo; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Snapinn Steven M; Harris Katherine E; Wedel Hans;
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(3):152-8.
2005: Oparil Suzanne; Silfani Tonous N; Walker J Findlay
Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals.
American journal of hypertension 2005;18(2 Pt 1):287-94.
2005: Moser Marvin; Sowers James R; Oparil Suzanne; Black Henry
New-onset diabetes in treated hypertensive patients--is it clinically significant? Roundtable discussion.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(2):90-5.
2005: Ibsen Hans; Olsen Michael H; Wachtell Kristian; Borch-Johnsen Knut; Lindholm Lars H; Mogensen Carl Erik; Dahlöf Björn; Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wan Ying
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Kizer Jorge R; Dahlöf Björn; Kjeldsen Sverre E; Julius Stevo; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Wachtell Kristian; Edelman Jonathan M; Snapinn Steven M; Harris Katherine E; Devereux Richard B
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension 2005;45(1):46-52.
2005: Kjeldsen Sverre E; Os Ingrid; Høieggen Aud; Beckey Kim; Gleim Gilbert W; Oparil Suzanne
Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2005;5(1):17-22.
2004: Bakris George L; Bank Alan J; Kass David A; Neutel Joel M; Preston Richard A; Oparil Suzanne
Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
American journal of hypertension 2004;17(12 Pt 2):23S-30S.
2004: Weber Michael; Basile Jan; Izzo Joseph; Oparil Suzanne
Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(12):699-705.
2004: Franco Veronica; Chen Yiu-Fai; Oparil Suzanne; Feng Ji An; Wang Dajun; Hage Fadi; Perry Gilbert
Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling.
Hypertension 2004;44(5):746-50.
2004: Li Peng; Oparil Suzanne; Feng Wenguang; Chen Yiu-Fai
Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells.
Journal of applied physiology (Bethesda, Md. : 1985) 2004;97(4):1550-8; discussion 1549.
2004: Oparil Suzanne
Interview with Suzanne Oparil, MD. Interview by Marvin Moser, MD.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(9):509-12.
2004: Miller Andrew P; Feng Wenguang; Xing Dongqi; Weathington Nathaniel M; Blalock J Edwin; Chen Yiu-Fai; Oparil Suzanne
Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries.
Circulation 2004;110(12):1664-9.
2004: Ibsen Hans; Wachtell Kristian; Olsen Michael H; Borch-Johnsen Knut; Lindholm Lars H; Mogensen Carl Erik; Dahlöf Björn; Devereux Richard B; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wan Ying;
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Franco Veronica; Oparil Suzanne; Carretero Oscar A
Hypertensive therapy: Part II.
Circulation 2004;109(25):3081-8.
2004: Franco Veronica; Oparil Suzanne; Carretero Oscar A
Hypertensive therapy: Part I.
Circulation 2004;109(24):2953-8.
2004: Reims H M; Kjeldsen S E; Brady W E; Dahlöf B; Devereux R B; Julius S; Beevers G; De Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):381-9.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabunmi Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):e29-50.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabumni Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):394-6.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabunmi Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Evidence-based guidelines for cardiovascular disease prevention in women.
Journal of the American College of Cardiology 2004;43(5):900-21.
2004: Mori Tatsuhiko; Chen Yiu-Fai; Feng Ji An; Hayashi Tetsuya; Oparil Suzanne; Perry Gilbert J
Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse.
Cardiovascular research 2004;61(4):771-9.
2004: Høieggen Aud; Alderman Michael H; Kjeldsen Sverre E; Julius Stevo; Devereux Richard B; De Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Chen Cong; Dahlöf Björn;
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Kidney international 2004;65(3):1041-9.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabunmi Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Evidence-based guidelines for cardiovascular disease prevention in women.
Circulation 2004;109(5):672-93.
2004: Xing Dongqi; Miller Andrew; Novak Lea; Rocha Ricardo; Chen Yiu-Fai; Oparil Suzanne
Estradiol and progestins differentially modulate leukocyte infiltration after vascular injury.
Circulation 2004;109(2):234-41.
2004: Reims Henrik M; Oparil Suzanne; Kjeldsen Sverre E; Devereux Richard B; Julius Stevo; Brady William E; Fyhrquist Frej; Ibsen Hans; Lindholm Lars H; Omvik Per; Wedel Hans; Beevers Gareth; de Faire Ulf; Kristianson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Dahlöf Björn;
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Blood pressure 2004;13(6):376-84.
2004: Os Ingrid; Oparil Suzanne; Gerdts Eva; Høieggen Aud
Essential hypertension in women.
Blood pressure 2004;13(5):272-8.
2003: Oparil Suzanne
Improving outcomes for women after coronary artery bypass grafting: a case for prevention.
The Journal of thoracic and cardiovascular surgery 2003;126(6):1704-6.
2003: Chobanian Aram V; Bakris George L; Black Henry R; Cushman William C; Green Lee A; Izzo Joseph L; Jones Daniel W; Materson Barry J; Oparil Suzanne; Wright Jackson T; Roccella Edward J;
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Hypertension 2003;42(6):1206-52.
2003: Wachtell Kristian; Ibsen Hans; Olsen Michael H; Borch-Johnsen Knut; Lindholm Lars H; Mogensen Carl Erik; Dahlöf Björn; Devereux Richard B; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Kristianson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Okin Peter M; Omvik Per; Oparil Suzanne; Wedel Hans; Snapinn Steven M; Aurup Peter
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Shelton J; Wang D; Gupta H; Wyss J M; Oparil S; White C R
The neointimal response to endovascular injury is increased in obese Zucker rats.
Diabetes, obesity & metabolism 2003;5(6):415-23.
2003: Oparil Suzanne; Zaman M Amin; Calhoun David A
Pathogenesis of hypertension.
Annals of internal medicine 2003;139(9):761-76.
2003: Miller Andrew P; Chen Yiu-Fai; Xing Dongqi; Feng Wenguang; Oparil Suzanne
Hormone replacement therapy and inflammation: interactions in cardiovascular disease.
Hypertension 2003;42(4):657-63.
2003: Burgess Ellen D; Lacourcière Yves; Ruilope-Urioste Luis M; Oparil Suzanne; Kleiman Jay H; Krause Scott; Roniker Barbara; Maurath Clement
Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension.
Clinical therapeutics 2003;25(9):2388-404.
2003: Kjeldsen Sverre E; Dahlöf Björn; Devereux Richard B; Lindholm Lars H; Nieminen Markku S; Oparil Suzanne; Wedel Hans;
Comparison of the SCOPE and LIFE results.
Journal of hypertension 2003;21(9):1772-3; author reply 1773.
2003: Devereux Richard B; Dahlöf Björn; Kjeldsen Sverre E; Julius Stevo; Aurup Peter; Beevers Gareth; Edelman Jonathan M; de Faire Ulf; Fyhrquist Frej; Helle Berg Sigrid; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Snapinn Steven; Wedel Hans;
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
Annals of internal medicine 2003;139(3):169-77.
2003: Li Peng; Oparil Suzanne; Sun Ju-Zhong; Thompson John A; Chen Yiu-Fai
Fibroblast growth factor mediates hypoxia-induced endothelin-- a receptor expression in lung artery smooth muscle cells.
Journal of applied physiology (Bethesda, Md. : 1985) 2003;95(2):643-51; discussion 863.
2003: Wang Dajun; Oparil Suzanne; Feng Ji An; Li Peng; Perry Gilbert; Chen Lan Bo; Dai Meiru; John Simon W M; Chen Yiu-Fai
Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse.
Hypertension 2003;42(1):88-95.
2003: Feng Ji An; Perry Gilbert; Mori Tatsuhiko; Hayashi Tetsuya; Oparil Suzanne; Chen Yiu-Fai
Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice.
Clinical and experimental pharmacology & physiology 2003;30(5-6):343-9.
2003: Chobanian Aram V; Bakris George L; Black Henry R; Cushman William C; Green Lee A; Izzo Joseph L; Jones Daniel W; Materson Barry J; Oparil Suzanne; Wright Jackson T; Roccella Edward J;
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
JAMA : the journal of the American Medical Association 2003;289(19):2560-72.
2003: Oparil Suzanne
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.
Hypertension 2003;41(5):1006-9.
2003: Flack John M; Oparil Suzanne; Pratt J Howard; Roniker Barbara; Garthwaite Susan; Kleiman Jay H; Yang Yonghong; Krause Scott L; Workman Diane; Saunders Elijah
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.
Journal of the American College of Cardiology 2003;41(7):1148-55.
2003: Peng Ning; Chambless Brandon D; Oparil Suzanne; Wyss J Michael
Alpha2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus.
Hypertension 2003;41(3):571-5.
2003: Miller Andrew P; Oparil Suzanne
Secondary prevention of coronary heart disease in women: a call to action.
Annals of internal medicine 2003;138(2):150-1.
2002: Ambalavanan Namasivayam; Philips Joseph B; Bulger Arlene; Oparil Suzanne; Chen Yiu-Fai
Endothelin-A receptor blockade in porcine pulmonary hypertension.
Pediatric research 2002;52(6):913-21.
2002: Kjeldsen Sverre E; Dahlöf Björn; Devereux Richard B; Julius Stevo; Aurup Peter; Edelman Jonathan; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristianson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Snapinn Steven; Wedel Hans;
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
JAMA : the journal of the American Medical Association 2002;288(12):1491-8.
2002: Lindholm Lars H; Ibsen Hans; Borch-Johnsen Knut; Olsen Michael Hecht; Wachtell Kristian; Dahlöf Björn; Devereux Richard B; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Kristianson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Aurup Peter; Edelman Jonathan M; Snapinn Steven;
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: Zaman Mohammad Amin; Oparil Suzanne; Calhoun David A
Drugs targeting the renin-angiotensin-aldosterone system.
Nature reviews. Drug discovery 2002;1(8):621-36.
2002: Li Guohong; Oparil Suzanne; Kelpke Stacey S; Chen Yiu-Fai; Thompson John A
Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.
Circulation 2002;106(7):854-9.
2002: Wei Chih-Chang; Tian Baohong; Perry Gilbert; Meng Qing Cheng; Chen Yiu-Fai; Oparil Suzanne; Dell'Italia Louis J
Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene.
American journal of physiology. Heart and circulatory physiology 2002;282(6):H2254-8.
2002: Oparil Suzanne
Do angiotensin receptor antagonists have benefits beyond blood pressure lowering?
Current hypertension reports 2002;4(3):219-20.
2002: Oparil S
Comparative antihypertensive efficacy of olmesartan: comparison with other angiotensin II receptor antagonists.
Journal of human hypertension 2002;16 Suppl 2():S17-23.
2002: Lindholm Lars H; Ibsen Hans; Dahlöf Björn; Devereux Richard B; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Julius Stevo; Kjeldsen Sverre E; Kristiansson Krister; Lederballe-Pedersen Ole; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans; Aurup Peter; Edelman Jonathan; Snapinn Steven;
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):1004-10.
2002: Dahlöf Björn; Devereux Richard B; Kjeldsen Sverre E; Julius Stevo; Beevers Gareth; de Faire Ulf; Fyhrquist Frej; Ibsen Hans; Kristiansson Krister; Lederballe-Pedersen Ole; Lindholm Lars H; Nieminen Markku S; Omvik Per; Oparil Suzanne; Wedel Hans;
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):995-1003.
2002: Franco Veronica; Oparil Suzanne
Hormone replacement therapy and hypertension.
Current opinion in nephrology and hypertension 2002;11(2):229-35.
2002: Dubey Raghvendra K; Oparil Suzanne; Imthurn Bruno; Jackson Edwin K
Sex hormones and hypertension.
Cardiovascular research 2002;53(3):688-708.
2002: Carlson Scott H; Oparil Suzanne; Chen Yiu-Fai; Wyss J Michael
Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice.
Hypertension 2002;39(2):214-8.
2002: Sun Ju-Zhong; Chen Shi-Juan; Majid-Hasan Erum; Oparil Suzanne; Chen Yiu-Fai
Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP.
American journal of physiology. Renal physiology 2002;282(2):F220-7.
2002: Oparil Suzanne
Are there meaningful differences in blood pressure control with current antihypertensive agents?
American journal of hypertension 2002;15(1 Pt 2):14S-21S.
2001: Fang Z; Carlson S H; Chen Y F; Oparil S; Wyss J M
Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;281(6):R1934-9.
2001: Tolbert T; Thompson J A; Bouchard P; Oparil S
Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model.
Circulation 2001;104(22):2740-5.
2001: Oparil S
Efficacy of perindopril in the treatment of systemic hypertension.
The American journal of cardiology 2001;88(7A):3i-12i.
2001: Oparil S
Hypertension. Introduction.
The American journal of cardiology 2001;88(7A):1i-2i.
2001: Thakkar R B; Oparil S;
What do international guidelines say about therapy?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2001;19(3):S23-31.
2001: Oparil S; Williams D; Chrysant S G; Marbury T C; Neutel J
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):283-91, 318.
2001: Sun J Z; Oparil S; Lucchesi P; Thompson J A; Chen Y F
Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cells.
American journal of physiology. Lung cellular and molecular physiology 2001;281(1):L155-63.
2001: Thakkar R B; Oparil S
Health outcomes associated with calcium antagonists.
Current hypertension reports 2001;3(3):228-9.
2001: Tolbert T; Oparil S
Cardiovascular effects of estrogen.
American journal of hypertension 2001;14(6 Pt 2):186S-193S.
2001: Thakkar R B; Oparil S
Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs.
Current hypertension reports 2001;3(3):227-8.
2001: Thakkar R B; Oparil S
Primary aldosteronism: a practical approach to diagnosis and treatment.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(3):189-95.
2001: Oparil S; Aurup P; Snavely D; Goldberg A
Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
The American journal of cardiology 2001;87(6):721-6.
2001: Perry G J; Mori T; Wei C C; Xu X Y; Chen Y F; Oparil S; Lucchesi P; Dell'Italia L J
Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.
Circulation 2001;103(7):1012-6.
2000: Chen Y F; Oparil S
Endothelial dysfunction in the pulmonary vascular bed.
The American journal of the medical sciences 2000;320(4):223-32.
2000: Kjeldsen S E; Dahlöf B; Devereux R B; Julius S; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
American journal of hypertension 2000;13(8):899-906.
2000: Bakir S E; Oparil S
Antihypertensive drug therapy in the third millennium: are there benefits beyond blood pressure?
Current hypertension reports 2000;2(3):291-4.
2000: Li G; Chen Y F; Kelpke S S; Oparil S; Thompson J A
Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.
Circulation 2000;101(25):2949-55.
2000: Bakir S; Mori T; Durand J; Chen Y F; Thompson J A; Oparil S
Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model.
Circulation 2000;101(20):2342-4.
2000: Mori T; Durand J; Chen Y; Thompson J A; Bakir S; Oparil S
Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery.
The American journal of cardiology 2000;85(10):1276-9.
2000: Li G; Chen S J; Oparil S; Chen Y F; Thompson J A
Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries.
Circulation 2000;101(12):1362-5.
2000: Oparil S
Newly emerging pharmacologic differences in angiotensin II receptor blockers.
American journal of hypertension 2000;13(1 Pt 2):18S-24S.
2000: Peng N; Wei C C; Oparil S; Wyss J M
The organum vasculosum of the lamina terminalis regulates noradrenaline release in the anterior hypothalamic nucleus.
Neuroscience 2000;99(1):149-56.
1999: Oparil S
Treating multiple-risk hypertensive populations.
American journal of hypertension 1999;12(11 Pt 2):121S-129S.
1999: Oparil S
Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension.
The American journal of cardiology 1999;84(10A):35S-41S.
1999: Su X; Brower G; Janicki J S; Chen Y F; Oparil S; Dell'Italia L J
Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Journal of molecular and cellular cardiology 1999;31(10):1927-36.
1999: Li G; Chen Y F; Greene G L; Oparil S; Thompson J A
Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.
Circulation 1999;100(15):1639-45.
1999: Oparil S; Levine J H; Zuschke C A; Gradman A H; Ripley E; Jones D W; Hardison J D; Cushing D J; Prasad R; Michelson E L
Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
The American journal of cardiology 1999;84(3):289-93.
1999: Wolkowicz P E; Urthaler F; Forrest C; Shen H; Durand J; Wei C C; Oparil S; Dell'Italia L J
2-Tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor.
Journal of molecular and cellular cardiology 1999;31(8):1405-12.
1999: Chrysant G S; Bakir S; Oparil S
Dietary salt reduction in hypertension--what is the evidence and why is it still controversial?
Progress in cardiovascular diseases 1999;42(1):23-38.
1999: Oparil S; Aronson S; Deeb G M; Epstein M; Levy J H; Luther R R; Prielipp R; Taylor A
Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises.
American journal of hypertension 1999;12(7):653-64.
1999: Bakir S; Oparil S
Recent outcome trials of newer antihypertensives.
Current hypertension reports 1999;1(3):238-40.
1999: Su X; Wei C C; Machida N; Bishop S P; Hankes G H; Dillon R A; Oparil S; Dell Italia L J
Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation.
Journal of molecular and cellular cardiology 1999;31(5):1033-45.
1999: Wei C C; Meng Q C; Palmer R; Hageman G R; Durand J; Bradley W E; Farrell D M; Hankes G H; Oparil S; Dell'Italia L J
Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.
Circulation 1999;99(19):2583-9.
1999: Oparil S; Oberman A
Nontraditional cardiovascular risk factors.
The American journal of the medical sciences 1999;317(3):193-207.
1999: Oparil S
Management of the hypertensive patient with coronary artery disease.
American journal of hypertension 1999;12(2 Pt 2):56S-62S.
1999: Oparil S
Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection.
Hypertension 1999;33(1 Pt 2):170-6.
1999: Oparil S
Long-term morbidity and mortality trials with amlodipine.
Journal of cardiovascular pharmacology 1999;33 Suppl 2():S1-6.
1998: Dahlöf B; Devereux R B; Julius S; Kjeldsen S E; Beevers G; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Hypertension 1998;32(6):989-97.
1998: Oparil S
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case study.
American journal of hypertension 1998;11(11 Pt 2):192S-194S.
1998: Reif M; White W B; Fagan T C; Oparil S; Flanagan T L; Edwards D T; Cushing D J; Michelson E L
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.
The American journal of cardiology 1998;82(8):961-5.
1998: Fallon M B; Abrams G A; Abdel-Razek T T; Dai J; Chen S J; Chen Y F; Luo B; Oparil S; Ku D D
Garlic prevents hypoxic pulmonary hypertension in rats.
The American journal of physiology 1998;275(2 Pt 1):L283-7.
1998: Oparil S; Guthrie R; Lewin A J; Marbury T; Reilly K; Triscari J; Witcher J A
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
Clinical therapeutics 1998;20(3):398-409.
1998: Oparil S
Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension.
American journal of hypertension 1998;11(4 Pt 3):88S-94S.
1997: White C R; Darley-Usmar V; Oparil S
No role for NO in estrogen-mediated vasoprotection?
Circulation 1997;96(9):2769-71.
1997: Balcells E; Meng Q C; Johnson W H; Oparil S; Dell'Italia L J
Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations.
The American journal of physiology 1997;273(4 Pt 2):H1769-74.
1997: White C R; Shelton J; Chen S J; Darley-Usmar V; Allen L; Nabors C; Sanders P W; Chen Y F; Oparil S
Estrogen restores endothelial cell function in an experimental model of vascular injury.
Circulation 1997;96(5):1624-30.
1997: Oparil S; Bernink P; Bursztyn M; Carney S; Kobrin I
Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension.
The American journal of cardiology 1997;80(4B):12C-19C.
1997: Dell'italia L J; Balcells E; Meng Q C; Su X; Schultz D; Bishop S P; Machida N; Straeter-Knowlen I M; Hankes G H; Dillon R; Cartee R E; Oparil S
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs.
The American journal of physiology 1997;273(2 Pt 2):H961-70.
1997: Oparil S; Kobrin I; Abernethy D R; Levine B S; Reif M C; Shepherd A M
Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension.
American journal of hypertension 1997;10(7 Pt 1):735-42.
1997: Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm L H; Nieminen M S; Omvik P; Oparil S; Wedel H
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
American journal of hypertension 1997;10(7 Pt 1):705-13.
1997: Tian B; Meng Q C; Chen Y F; Krege J H; Smithies O; Oparil S
Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function.
Hypertension 1997;30(1 Pt 1):128-33.
1997: Dell'Italia L J; Meng Q C; Balcells E; Wei C C; Palmer R; Hageman G R; Durand J; Hankes G H; Oparil S
Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.
The Journal of clinical investigation 1997;100(2):253-8.
1997: Chen S J; Chen Y F; Opgenorth T J; Wessale J L; Meng Q C; Durand J; DiCarlo V S; Oparil S
The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Journal of cardiovascular pharmacology 1997;29(6):713-25.
1997: Calhoun D A; Oparil S
High blood pressure in women.
International journal of fertility and women's medicine 1997;42(3):198-205.
1997: Oparil S; Levine R L; Chen S J; Durand J; Chen Y F
Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment.
Circulation 1997;95(5):1301-7.
1996: Peng N; Oparil S; Meng Q C; Wyss J M
Atrial natriuretic peptide regulation of noradrenaline release in the anterior hypothalamic area of spontaneously hypertensive rats.
The Journal of clinical investigation 1996;98(9):2060-5.
1996: Levine R L; Chen S J; Durand J; Chen Y F; Oparil S
Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery.
Circulation 1996;94(9):2221-7.
1996: Oparil S
Classic papers symposium of the Southern Clinical Research meetings: white coat hypertension--fact or fancy?
The American journal of the medical sciences 1996;312(5):219-20.
1996: Oparil S; Dyke S; Harris F; Kief J; James D; Hester A; Fitzsimmons S
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension.
Clinical therapeutics 1996;18(5):797-810.
1996: Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
Clinical therapeutics 1996;18(4):608-25.
1996: Oparil S; Chen Y F; Peng N; Wyss J M
Anterior hypothalamic norepinephrine, atrial natriuretic peptide, and hypertension.
Frontiers in neuroendocrinology 1996;17(2):212-46.
1996: Peng N; Meng Q C; Oparil S; Wyss J M
Acute saline infusion decreases norepinephrine release in the anterior hypothalamic area.
Hypertension 1996;27(3 Pt 2):578-83.
1996: Zhu S T; Chen Y F; Wyss J M; Nakao K; Imura H; Oparil S; Calhoun D A
Atrial natriuretic peptide blunts arterial baroreflex in spontaneously hypertensive rats.
Hypertension 1996;27(2):297-302.
1996: Chen S J; Li H; Durand J; Oparil S; Chen Y F
Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.
Circulation 1996;93(3):577-84.
1995: Chen S J; Chen Y F; Meng Q C; Durand J; Dicarlo V S; Oparil S
Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats.
Journal of applied physiology (Bethesda, Md. : 1985) 1995;79(6):2122-31.
1995: Dell'Italia L J; Meng Q C; Balcells E; Straeter-Knowlen I M; Hankes G H; Dillon R; Cartee R E; Orr R; Bishop S P; Oparil S
Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation.
The American journal of physiology 1995;269(6 Pt 2):H2065-73.
1995: Calhoun D A; Oparil S
Racial differences in the pathogenesis of hypertension.
The American journal of the medical sciences 1995;310 Suppl 1():S86-90.
1995: DiCarlo V S; Chen S J; Meng Q C; Durand J; Yano M; Chen Y F; Oparil S
ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.
The American journal of physiology 1995;269(5 Pt 1):L690-7.
1995: Meng Q C; Durand J; Chen Y F; Oparil S
Effects of dietary salt on angiotensin peptides in kidney.
Journal of the American Society of Nephrology : JASN 1995;6(4):1209-15.
1995: Meng Q C; Balcells E; Dell'Italia L; Durand J; Oparil S
Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue.
Biochemical pharmacology 1995;50(9):1445-50.
1995: Calhoun D A; Zhu S T; Chen Y F; Oparil S
Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats.
Hypertension 1995;26(2):285-9.
1995: Oparil S
SSCI Founders Medal recipient's address.
The American journal of the medical sciences 1995;310(1):4-5.
1995: Peng N; Meng Q C; King K; Oparil S; Wyss J M
Acute hypertension increases norepinephrine release in the anterior hypothalamic area.
Hypertension 1995;25(4 Pt 2):828-33.
1995: Li H; Oparil S; Meng Q C; Elton T S; Chen Y F
Selective downregulation of ANP-clearance-receptor gene expression in lung of rats adapted to hypoxia.
The American journal of physiology 1995;268(2 Pt 1):L328-35.
1995: Oparil S; Chen S J; Meng Q C; Elton T S; Yano M; Chen Y F
Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
The American journal of physiology 1995;268(1 Pt 1):L95-100.
1994: Chen S J; Chen Y F; Miller D M; Li H; Oparil S
Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.
Circulation 1994;90(5):2468-73.
1994: Calhoun D A; Mutinga M L; Wyss J M; Oparil S
Muscle sympathetic nervous system activity in black and Caucasian hypertensive subjects.
Journal of hypertension 1994;12(11):1291-6.
1994: Chen Y F; Yang R H; Meng Q C; Cragoe E J; Oparil S
Sodium-proton (Na+/H+) exchange inhibition increases blood pressure in spontaneously hypertensive rat.
The American journal of the medical sciences 1994;308(3):145-51.
1994: Li H; Chen S J; Chen Y F; Meng Q C; Durand J; Oparil S; Elton T S
Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia.
Journal of applied physiology (Bethesda, Md. : 1985) 1994;77(3):1451-9.
1994: Calhoun D A; Zhu S; Wyss J M; Oparil S
Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats.
Hypertension 1994;24(1):1-7.
1994: Li H; Elton T S; Chen Y F; Oparil S
Increased endothelin receptor gene expression in hypoxic rat lung.
The American journal of physiology 1994;266(5 Pt 1):L553-60.
1994: Oparil S; Yang R H; Jin H G; Chen S J; Meng Q C; Berecek K H; Wyss J M
Role of anterior hypothalamic angiotensin II in the pathogenesis of salt sensitive hypertension in the spontaneously hypertensive rat.
The American journal of the medical sciences 1994;307 Suppl 1():S26-37.
1994: Chen Y F; Li H; Elton T S; Yang R H; Jin H; Oparil S
The role of atrial natriuretic peptide and endothelin in hypoxia induced pulmonary hypertension.
The Chinese journal of physiology 1994;37(3):165-83.
1993: Calhoun D A; Mutinga M L; Collins A S; Wyss J M; Oparil S
Normotensive blacks have heightened sympathetic response to cold pressor test.
Hypertension 1993;22(6):801-5.
1993: Lipke D W; McCarthy K J; Elton T S; Arcot S S; Oparil S; Couchman J R
Coarctation induces alterations in basement membranes in the cardiovascular system.
Hypertension 1993;22(5):743-53.
1993: Nakamura Y; Calhoun D A; Chen Y F; Wyss J M; Oparil S
Excitatory sympathetic reflex in NaCl-sensitive spontaneously hypertensive rats.
Hypertension 1993;22(3):285-91.
1993: Meng Q C; Durand J; Chen Y F; Oparil S
Simplified method for quantitation of angiotensin peptides in tissue.
Journal of chromatography 1993;614(1):19-25.
1992: Elton T S; Oparil S; Taylor G R; Hicks P H; Yang R H; Jin H; Chen Y F
Normobaric hypoxia stimulates endothelin-1 gene expression in the rat.
The American journal of physiology 1992;263(6 Pt 2):R1260-4.
1992: Yang R H; Jin H; Chen S J; Wyss J M; Oparil S
Blocking hypothalamic AT1 receptors lowers blood pressure in salt-sensitive rats.
Hypertension 1992;20(6):755-62.
1992: Jin H; Yang R; Chen Y F; Oparil S
Ganglion atrial natriuretic peptide in NaCl sensitive spontaneously hypertensive rats.
American journal of hypertension 1992;5(11):806-10.
1992: King S J; Oparil S
Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells.
The American journal of physiology 1992;263(4 Pt 1):C743-9.
1992: Jin H; Yang R H; Calhoun D A; Wyss J M; Oparil S
Atrial natriuretic peptide modulates baroreceptor reflex in spontaneously hypertensive rat.
Hypertension 1992;20(3):374-9.
1992: Yang R; Jin H; Wyss J M; Chen Y F; Oparil S
Salt supplementation does not alter the pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.
Hypertension 1992;20(2):242-6.
1992: Yang R H; Jin H; Wyss J M; Oparil S
Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.
Hypertension 1992;19(5):475-81.
1992: Chen Y F; Naftilan A J; Oparil S
Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats.
Hypertension 1992;19(5):456-63.
1992: Wyss J M; Oparil S; Sripairojthikoon W
Neuronal control of the kidney: contribution to hypertension.
Canadian journal of physiology and pharmacology 1992;70(5):759-70.
1992: Jin H; Mathews C; Chen Y F; Yang R; Wyss J M; Esunge P; Oparil S
Effects of acute and chronic blockade of neutral endopeptidase with Sch 34826 on NaCl-sensitive hypertension in spontaneously hypertensive rats.
American journal of hypertension 1992;5(4 Pt 1):210-8.
1992: Chen Y F; Elton T S; Oparil S
Quantitation of hypothalamic atrial natriuretic peptide messenger RNA in hypertensive rats.
Hypertension 1992;19(3):296-300.
1992: Yang R H; Jin H K; Wyss J M; Chen Y F; Oparil S
Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.
Hypertension 1992;19(2):198-205.
1991: Oparil S; Chen Y F; Wang R P
Atrial natriuretic peptide inhibits sympathetic outflow in NaCl-sensitive spontaneously hypertensive rats.
Journal of hypertension 1991;9(12):1177-85.
1991: Chen C W; Chen Y F; Meng Q C; Wyss J M; Oparil S
Decreased norepinephrine release in anterior hypothalamus of NaCl-sensitive spontaneously hypertensive rats during high NaCl intake.
Brain research 1991;565(1):135-41.
1991: Jin H; Yang R H; Chen Y F; Jackson R M; Itoh H; Mukoyama M; Nakao K; Imura H; Oparil S
Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats.
Journal of applied physiology (Bethesda, Md. : 1985) 1991;71(3):807-14.
1991: Jin H K; Yang R H; Wyss J M; Chen Y F; Oparil S
Intrahypothalamic clonidine infusion prevents NaCl-sensitive hypertension.
Hypertension 1991;18(2):224-9.
1991: Oparil S; Chen Y F; Jin H K; Yang R H; Wyss J M
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats via sympatholytic and renal effects.
The American journal of clinical nutrition 1991;54(1 Suppl):227S-236S.
1991: Oparil S; Calhoun D A
The calcium antagonists in the 1990s. An overview.
American journal of hypertension 1991;4(7 Pt 2):396S-405S.
1991: Jin H K; Yang R H; Esunge P; Chen Y F; Durand J; Oparil S
Antihypertensive effect of cicletanine is exaggerated in NaCl-sensitive hypertension.
The American journal of the medical sciences 1991;301(6):383-9.
1991: Jin H K; Yang R H; Chen Y F; Wyss J M; Oparil S
Altered stores of atrial natriuretic peptide in specific brain nuclei of NaCl-sensitive spontaneously hypertensive rats.
American journal of hypertension 1991;4(5 Pt 1):449-55.
1991: Calhoun D A; Wyss J M; Oparil S
High NaCl diet enhances arterial baroreceptor reflex in NaCl-sensitive spontaneously hypertensive rats.
Hypertension 1991;17(3):363-8.
1991: King S J; Oparil S; Berecek K H
Neuronal angiotensin-converting enzyme (ACE) gene expression is increased by converting enzyme inhibitors (CEI).
Molecular and cellular neurosciences 1991;2(1):13-20.
1990: Yang R H; Jin H K; Chen Y F; Wyss J M; Oparil S
Blockade of endogenous anterior hypothalamic atrial natriuretic peptide with monoclonal antibody lowers blood pressure in spontaneously hypertensive rats.
The Journal of clinical investigation 1990;86(6):1985-90.
1990: Jirakulsomchok S; Mozaffari M S; Oparil S; Wyss J M
Dietary Ca2+ increases natriuretic and diuretic responses to volume loading in NaCl-sensitive spontaneously hypertensive rats.
Journal of hypertension 1990;8(10):947-51.
1990: Wyss J M; Yang R H; Oparil S
Lesions of the anterior hypothalamic area increase arterial pressure in NaCl-sensitive spontaneously hypertensive rats.
Journal of the autonomic nervous system 1990;31(1):21-9.
1990: Oparil S; Wyss J M; Yang R H; Jin H K; Chen Y F
Dietary Ca2+ prevents NaCl-sensitive hypertension in spontaneously hypertensive rats by a sympatholytic mechanism.
American journal of hypertension 1990;3(8 Pt 2):179S-188S.
1990: Chen Y F; Meng Q C; Wyss J M; Jin H K; Rogers C F; Oparil S
NaCl does not affect hypothalamic noradrenergic input in deoxycorticosterone acetate/NaCl and Dahl salt-sensitive rats.
Hypertension 1990;16(1):55-62.
1990: Meng Q C; Chen Y F; Oparil S; Cragoe E J
High-performance liquid chromatographic determination of amiloride and its analogues in rat plasma.
Journal of chromatography 1990;529(1):201-9.
1990: Jin H; Chen Y F; Yang R H; Jackson R M; Oparil S
Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;68(6):2413-8.
1990: Jin H K; Yang R H; Chen Y F; Oparil S
Atrial natriuretic factor prevents NaCl-sensitive hypertension in spontaneously hypertensive rats.
Hypertension 1990;15(2):170-6.
1990: Mozaffari M S; Jirakulsomchok S; Oparil S; Wyss J M
Changes in cerebrospinal fluid Na+ concentration do not underlie hypertensive responses to dietary NaCl in spontaneously hypertensive rats.
Brain research 1990;506(1):149-52.
1990: Jin H; Yang R H; Chen Y F; Jackson R M; Oparil S
Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.
The Journal of clinical investigation 1990;85(1):115-20.
1989: Thornton R M; Wyss J M; Oparil S
Impaired reflex response to volume expansion in NaCl-sensitive spontaneously hypertensive rats.
Hypertension 1989;14(5):518-23.
1989: Jin H; Chen Y F; Yang R H; Oparil S
Atrial natriuretic factor in NaCl-sensitive and NaCl-resistant spontaneously hypertensive rats.
Hypertension 1989;14(4):404-12.
1989: Jin H K; Chen Y F; Yang R H; McKenna T M; Jackson R M; Oparil S
Vasopressin lowers pulmonary artery pressure in hypoxic rats by releasing atrial natriuretic peptide.
The American journal of the medical sciences 1989;298(4):227-36.
1989: Wyss J M; Chen Y F; Meng Q C; Jin H K; Jirikulsomchok S; Oparil S
Dietary Ca2+ prevents NaCl-induced exacerbation of hypertension and increases hypothalamic norepinephrine turnover in spontaneously hypertensive rats.
Journal of hypertension 1989;7(9):711-9.
1989: Sripairojthikoon W; Oparil S; Wyss J M
Renal nerve contribution to NaCl-exacerbated hypertension in spontaneously hypertensive rats.
Hypertension 1989;14(2):184-90.
1989: Jin H K; Yang R H; Chen Y F; Wyss J M; Oparil S
Dietary NaCl loading enhances antihypertensive effect of guanabenz in spontaneously hypertensive rats.
American journal of hypertension 1989;2(6 Pt 1):435-9.
1989: Oparil S; Yang R H; Jin H K; Wyss J M; Chen Y F
Central mechanisms of hypertension.
American journal of hypertension 1989;2(6 Pt 1):477-85.
1989: King S J; Booyse F M; Lin P H; Traylor M; Narkates A J; Oparil S
Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis.
The American journal of physiology 1989;256(6 Pt 1):C1231-8.
1989: Jin H K; Yang R H; Chen Y F; Thornton R M; Jackson R M; Oparil S
Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia.
Journal of applied physiology (Bethesda, Md. : 1985) 1989;66(1):151-60.
1989: Meng Q C; King S J; Chen Y F; Delucas L J; Oparil S
Purification of angiotensin-converting enzyme by gel high-performance liquid chromatography.
Journal of chromatography 1989;461():271-5.
1989: Yang R H; Jin H K; Chen Y F; Oparil S; Wyss J M
Dietary Ca2+ supplementation prevents the exaggerated responsiveness of anterior hypothalamic alpha 2-adrenoceptors in NaCl-loaded spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1989;13(1):162-7.
1989: Meng Q C; Chen Y F; Oparil S
A simple method for concentration of biogenic amines and their metabolites from biological samples for analysis by HPLC-EC.
Life sciences 1989;44(17):1207-13.
1988: Jin H K; Yang R H; Thornton R M; Chen Y F; Jackson R; Oparil S
Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats.
Journal of applied physiology (Bethesda, Md. : 1985) 1988;65(4):1729-35.
1988: Wyss J M; Yang R H; Jin H K; Oparil S
Hypothalamic microinjection of alpha 2-adrenoceptor agonists causes greater sympathoinhibition in spontaneously hypertensive rats on high NaCl diets.
Journal of hypertension 1988;6(10):805-13.
1988: Oparil S; Narkates A J; Jackson R M; Ann H S
Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats.
Journal of applied physiology (Bethesda, Md. : 1985) 1988;65(1):218-27.
1988: Meng Q C; Chen Y F; Delucas L J; Oparil S
Effect of steric exclusion on the separation of proteins by hydrophilic size-exclusion chromatography.
Journal of chromatography 1988;445(1):29-36.
1988: Chen Y F; Yang R H; Jin H; Wyss J M; Cragoe E J; Oparil S
Exaggerated depressor response to 6-iodoamiloride in NaCl-sensitive spontaneously hypertensive rats.
The American journal of the medical sciences 1988;296(1):78-83.
1988: Jin H K; Chen Y F; Yang R H; Meng Q C; Oparil S
Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats.
Hypertension 1988;11(6 Pt 2):739-44.
1988: Klangkalya B; Sripairojthikoon W; Oparil S; Wyss J M
High NaCl diet increases anterior hypothalamic alpha 2-adrenoceptors in SHR.
Brain research 1988;451(1-2):77-84.
1988: Oparil S; Chen Y F; Meng Q C; Yang R H; Jin H K; Wyss J M
The neural basis of salt sensitivity in the rat: altered hypothalamic function.
The American journal of the medical sciences 1988;295(4):360-9.
1988: Chen Y F; Meng Q C; Wyss J M; Jin H; Oparil S
High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats.
Hypertension 1988;11(1):55-62.
1988: Jackson R M; Ann H S; Oparil S
Hypoxia-induced oxygen tolerance: maintenance of endothelial metabolic function.
Experimental lung research 1988;14 Suppl():887-96.
1988: Oparil S; Meng Q C; Chen Y F; Yang R H; Jin H K; Wyss J M
Genetic basis of NaCl-sensitive hypertension.
Journal of cardiovascular pharmacology 1988;12 Suppl 3():S56-69.
1987: Wyss J M; Sripairojthikoon W; Oparil S
Failure of renal denervation to attenuate hypertension in Dahl NaCl-sensitive rats.
Canadian journal of physiology and pharmacology 1987;65(12):2428-32.
1987: Oparil S; Horton R; Wilkins L H; Irvin J; Hammett D K
Antihypertensive effect of enalapril in essential hypertension: role of prostacyclin.
The American journal of the medical sciences 1987;294(6):395-402.
1987: Jin H; Oparil S; Ann H S; Yang R; Jackson R M
Hypoxia-induced inhibition of converting enzyme activity: role in vascular regulation.
Journal of applied physiology (Bethesda, Md. : 1985) 1987;63(3):1012-8.
1987: Oparil S; Sripairojthikoon W; Wyss J M
The renal afferent nerves in the pathogenesis of hypertension.
Canadian journal of physiology and pharmacology 1987;65(8):1548-58.
1987: Wyss J M; Liumsiricharoen M; Sripairojthikoon W; Brown D; Gist R; Oparil S
Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat.
Hypertension 1987;9(6 Pt 2):III171-5.
1987: Igarashi Y; Chen Y F; Wyss J M; Lindheimer M D; Oparil S
Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat.
Pharmacology 1987;35(4):194-202.
1986: Jackson R M; Narkates A J; Oparil S
Impaired pulmonary conversion of angiotensin I to angiotensin II in rats exposed to chronic hypoxia.
Journal of applied physiology (Bethesda, Md. : 1985) 1986;60(4):1121-7.

Sign-in to see more